Search Result "Intraperitoneal Chemotherapy"
Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7 Issue: 5 Year: 2007 Page: 511-519
Author(s): S. Rekhraj, J. Kinross, S. Prabhudesai, A. Darzi, P. Ziprin
Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer
Ebook: Topics in Anti-Cancer Research
Volume: 1 Year: 2012
Author(s): Paul H. Sugarbaker,Dal Yoo,O. Anthony Stuart,Lana Bijelic
Doi: 10.2174/9781608054787112010009
Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 174-179
Author(s): Anil Kamath, Dal Yoo, Oswald A. Stuart, Lana Bijelic, Paul H. Sugarbaker
Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer:Efficacy, Toxicity, and Future Directions
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 3 Year: 2007 Page: 169-173
Author(s): Maurie Markman
Intraperitoneal Drug Therapy: An Advantage
Journal: Current Clinical Pharmacology
Volume: 5 Issue: 2 Year: 2010 Page: 82-88
Author(s): Kunal Chaudhary, Shadi Haddadin, Ravi Nistala, Chris Papageorgio
Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) in Patients with Advanced Ovarian Cancer: A 2-year SurvivalAnalysis Study
Journal: Current Women`s Health Reviews
Volume: 20 Issue: 4 Year: 2024 Page: 121-130
Author(s): Azadeh Jafari Ashtiani,Maryam Sadat Hosseini
Clinical Efficacy of Combination Intravenous and Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis
Journal: Current Pharmaceutical Biotechnology
Volume: 19 Issue: 12 Year: 2018 Page: 956-962
Author(s): Suyun Zhang,Rui Feng,Zhangchi Pan,Mengxin Lin,Xiaobing Huang,Tao Jiang,Qian Xu,Qiang Chen,Sheng Yang
Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 25 Year: 2012 Page: 3793-3803
Author(s): Stefaan Mulier,Jean-Pierre Claes,Vincent Dierieck,Jean-Olivier Amiel,Jean-Philippe Pahaut,Luc Marcelis,Fabienne Bastin,Denis Vanderbeeken,Claude Finet,Sophie Cran,Thierry Velu
Calcium Carbonate Microparticles as Carriers of 224Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
Journal: Current Radiopharmaceuticals
Volume: 14 Issue: 2 Year: 2021 Page: 145-153
Author(s): Ruth Gong Li,Elisa Napoli,Ida Sofie Jorstad,Tina Bjørnlund Bønsdorff,Asta Juzeniene,Ãyvind Sverre Bruland,Roy Hartvig Larsen,Sara Westrøm
Targeted Alpha Therapy with 227Th-trastuzumab of Intraperitoneal Ovarian Cancer in Nude Mice
Journal: Current Radiopharmaceuticals
Volume: 6 Issue: 2 Year: 2013 Page: 106-116
Author(s): Helen Heyerdahl,Nasir Abbas,Kristine Sponheim,Camilla Mollatt,Oyvind Bruland,Jostein Dahle